369 related items for PubMed ID: 9850360
1. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ, Stampone P, O'Connor BJ.
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[Abstract] [Full Text] [Related]
2. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[Abstract] [Full Text] [Related]
3. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[Abstract] [Full Text] [Related]
4. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
Thompson PJ, Davies RJ, Young WF, Grossman AB, Donnell D.
Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
[Abstract] [Full Text] [Related]
5. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
Boulet LP, Cartier A, Ernst P, Larivée P, Laviolette M.
Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
[Abstract] [Full Text] [Related]
6. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
Matthys H, Nowak D, Hader S, Kunkel G.
Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
[Abstract] [Full Text] [Related]
7. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
[Abstract] [Full Text] [Related]
8. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
[Abstract] [Full Text] [Related]
9. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF, Buist AS.
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[Abstract] [Full Text] [Related]
10. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.
Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
[Abstract] [Full Text] [Related]
11. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice GL.
J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
[Abstract] [Full Text] [Related]
12. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
Nayak A, Lanier R, Weinstein S, Stampone P, Welch M.
Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
[Abstract] [Full Text] [Related]
13. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
Seale JP, Harrison LI.
Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
[Abstract] [Full Text] [Related]
14. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
Br J Clin Pract; 1997 Jun; 51(1):11-5. PubMed ID: 9158265
[Abstract] [Full Text] [Related]
15. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[Abstract] [Full Text] [Related]
16. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
[Abstract] [Full Text] [Related]
17. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
J Aerosol Med; 2002 Jan; 15(4):407-14. PubMed ID: 12581507
[Abstract] [Full Text] [Related]
18. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
Milanowski J, Qualtrough J, Perrin VL.
Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
[Abstract] [Full Text] [Related]
19. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
20. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H, Muir JF, Pieters WR.
Respiration; 2001 Mar; 68(5):517-26. PubMed ID: 11694816
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
